AYI insider sells 4,489 shares at $362.18–$370.46; 6,056 remain

Acuity Inc. (AYI) reported insider share sales by an executive.

Rhea-AI Filing Summary

Acuity Inc. (AYI) reported insider share sales by an executive. SVP & General Counsel Barry R. Goldman sold a total of 4,489 shares of common stock on 10/28/2025 across multiple transactions. Reported weighted-average prices for the tranches ranged from $362.18 to $370.46, with specific batches reported at $362.80, $363.79, $364.94, $365.75, $366.65, $368.49, and $370.23. Following these sales, the reporting person directly beneficially owned 6,056 shares.

The prices reflect weighted averages for numerous trades within disclosed ranges, and the reporting person undertook to provide full trade-by-trade details upon request.

Insider Trade Summary

Net Seller: 4,489 shares

Net Sell 7 txns

Insider GOLDMAN BARRY R

Role SVP & General Counsel

Sold 4,489 shs ($1.64M)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,007	$362.80	$365K
Sale	Common Stock	378	$363.79	$138K
Sale	Common Stock	1,839	$364.94	$671K
Sale	Common Stock	470	$365.75	$172K
Sale	Common Stock	102	$366.65	$37K
Sale	Common Stock	493	$368.49	$182K
Sale	Common Stock	200	$370.23	$74K

Holdings After Transaction: Common Stock — 6,056 shares (Direct)

Footnotes (7)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.18 to $363.11, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.40 to $364.39, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.41 to $365.23, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.53 to $365.99, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
5. F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.08 to $366.66, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
6. F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.25 to $368.66, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
7. F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $370.00 to $370.46, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AYI disclose in this Form 4?

An officer, Barry R. Goldman, reported selling 4,489 shares of AYI common stock on 10/28/2025 across multiple trades.

What prices were the AYI shares sold at?

Sales were reported at weighted-average prices, with ranges from $362.18 to $370.46 across the disclosed tranches.

How many AYI shares does the insider hold after the sales?

After the transactions, the reporting person directly beneficially owned 6,056 shares.

Who is the reporting person in AYI's filing?

The reporting person is Barry R. Goldman, AYI’s SVP & General Counsel.

Were the transactions single trades or multiple trades?

They were multiple transactions with reported weighted-average prices and disclosed price ranges for each tranche.

What is the AYI ticker and issuer name in the filing?

Issuer: Acuity Inc. (DE); Ticker: AYI.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/30/2025 - 04:09 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GOLDMAN BARRY R

(Last) (First) (Middle)

C/O ACUITY INC.

1170 PEACHTREE STREET, NE, SUITE 1200

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACUITY INC. (DE) [ AYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
10/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/28/2025		S		1,007	D	$362.8(1)	9,538	D
Common Stock	10/28/2025		S		378	D	$363.79(2)	9,160	D
Common Stock	10/28/2025		S		1,839	D	$364.94(3)	7,321	D
Common Stock	10/28/2025		S		470	D	$365.75(4)	6,851	D
Common Stock	10/28/2025		S		102	D	$366.65(5)	6,749	D
Common Stock	10/28/2025		S		493	D	$368.49(6)	6,256	D
Common Stock	10/28/2025		S		200	D	$370.23(7)	6,056	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.18 to $363.11, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.40 to $364.39, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.41 to $365.23, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.53 to $365.99, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.08 to $366.66, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.25 to $368.66, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $370.00 to $370.46, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Remarks:

	/s/ Chanda Kirchner, Attorney-in-Fact for Barry R. Goldman	10/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.